Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials.
Saved in:
| Title: | Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials. |
|---|---|
| Authors: | Gamper, Eva M.1 (AUTHOR) eva.gamper@iipcor.org, Musoro, Jammbe Z.2 (AUTHOR), Coens, Corneel2 (AUTHOR), Stelmes, Jean-Jacques3 (AUTHOR), Falato, Claudette2 (AUTHOR), Groenvold, Mogens4 (AUTHOR), Velikova, Galina5 (AUTHOR), Cocks, Kim6 (AUTHOR), Flechtner, Hans-Henning7 (AUTHOR), King, Madeleine T.8 (AUTHOR), Bottomley, Andrew2 (AUTHOR), EORTC Genito-Urinary Tract Cancer Group and Quality of Life Groups (CORPORATE AUTHOR) |
| Source: | BMC Cancer. 10/7/2021, Vol. 21 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-021-08609-7 |
